Evolution of eligibility criteria for diffuse large B-cell lymphoma randomised controlled trials over 30 years.

导出 LinkOut

翻译打印收藏纠错

作者： Zoe,Loh ^[1] ; Ross,Salvaris ^[1] ; Geoffrey,Chong ^[2] ; Leonid,Churilov ^[1] ; Kate,Manos ^[3] ; Allison,Barraclough ^[3] ; Eliza A,Hawkes ^[1]

作者单位： Department of Medical Oncology and Clinical Haematology, Olivia Newton John Cancer Research and Wellness Centre at Austin Health, Heidelberg, Vic., Australia. ^[1] Department of Haematology, Monash Health, Clayton, Vic., Australia. ^[2] Melbourne Medical School, University of Melbourne, Melbourne, Vic., Australia. ^[3] Department of Haematology, Eastern Health, Melbourne, Vic., Australia. ^[4]

关键词 diffuse large B-cell lymphoma eligibility criteria randomised controlled trials recruitment

主题词临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);历史, 20世纪(History, 20th Century);历史, 21世纪(History, 21st Century);人类(Humans);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);病人遴选(Patient Selection);随机对照试验(主题)(Randomized Controlled Trials as Topic)

DOI 10.1111/bjh.17436

PMID 33851428

发布时间 2021-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交